Armistice Capital’s Exelon EXC Stock Holding History

Armistice Capital’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,836	Closed	-$298K	–	342
2025 Q4	$298K	Buy	+6,836	New	+$312K	﹤0.01%	271

Other funds holding EXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Armistice Capital's EXC Position: Q1 2026 in Review

Armistice Capital sold out of Exelon (EXC) in Q1 2026, closing a stake of 6,836 shares — an estimated $298K sold.

Armistice Capital first reported a position in EXC in Q4 2025 and held it in 1 quarter. The position peaked at $298K in Q4 2025. 1,286 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

Armistice Capital reported no remaining Exelon position as of Q1 2026 after selling out during the quarter.
Armistice Capital sold 6,836 Exelon shares in Q1 2026, an estimated $298K.
Armistice Capital first reported a position in Exelon in Q4 2025 and held it in 1 quarter.
Armistice Capital's Exelon position peaked at $298K in Q4 2025.
1,286 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.